Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Population pharmacokinetics of ethanol in drinking drivers using breath measures.

Clardy DO.

Ther Drug Monit. 2004 Aug;26(4):391-400.

PMID:
15257069
[PubMed - indexed for MEDLINE]
2.

Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen.

Jelliffe R.

Am J Nephrol. 2002 Jul-Aug;22(4):320-4.

PMID:
12169862
[PubMed - indexed for MEDLINE]
3.

Failure of traditional trough levels to predict tacrolimus concentrations.

Macchi-Andanson M, Charpiat B, Jelliffe RW, Ducerf C, Fourcade N, Baulieux J.

Ther Drug Monit. 2001 Apr;23(2):129-33.

PMID:
11294512
[PubMed - indexed for MEDLINE]
4.

Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

Jelliffe R, Schumitzky A, Van Guilder M.

Ther Drug Monit. 2000 Jun;22(3):354-65.

PMID:
10850405
[PubMed - indexed for MEDLINE]
5.

Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.

Jelliffe R, Bayard D, Milman M, Van Guilder M, Schumitzky A.

Ther Drug Monit. 2000 Jun;22(3):346-53.

PMID:
10850404
[PubMed - indexed for MEDLINE]
6.

Goal-oriented, model-based drug regimens: setting individualized goals for each patient.

Jelliffe R.

Ther Drug Monit. 2000 Jun;22(3):325-9. Review.

PMID:
10850402
[PubMed - indexed for MEDLINE]
7.

A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting.

Charpiat B, Falconi I, Bréant V, Jelliffe RW, Sab JM, Ducerf C, Fourcade N, Thomasson A, Baulieux J.

Ther Drug Monit. 1998 Apr;20(2):158-64.

PMID:
9558129
[PubMed - indexed for MEDLINE]
8.

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.

Jelliffe RW, Schumitzky A, Bayard D, Milman M, Van Guilder M, Wang X, Jiang F, Barbaut X, Maire P.

Clin Pharmacokinet. 1998 Jan;34(1):57-77. Review.

PMID:
9474473
[PubMed - indexed for MEDLINE]
9.

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide.

Peloquin CA, Jaresko GS, Yong CL, Keung AC, Bulpitt AE, Jelliffe RW.

Antimicrob Agents Chemother. 1997 Dec;41(12):2670-9.

PMID:
9420037
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methods.

Jelliffe RW, Gomis P, Tahani B, Ruskin J, Sattler FR.

Ther Drug Monit. 1997 Aug;19(4):450-9.

PMID:
9263388
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients.

Fouque D, Peng SC, Kopple JD.

Kidney Int. 1995 Mar;47(3):869-75.

PMID:
7752586
[PubMed - indexed for MEDLINE]
12.

Adaptive control of therapeutic drug regimens relations between clinical situations: outcomes and simulations using nonlinear dynamic models.

Maire PH, Barbaut X, Thalabard JC, Vergnaud JM, Roux D, Roy M, Jelliffe RW.

Medinfo. 1995;8 Pt 2:1111-5.

PMID:
8591382
[PubMed - indexed for MEDLINE]
13.

Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapy.

Jelliffe RW, Bayard D, Schumitzky A, Milman M, Van Guilder M.

Medinfo. 1995;8 Pt 2:1106-10.

PMID:
8591381
[PubMed - indexed for MEDLINE]
14.

Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation.

Dodge WF, Jelliffe RW, Zwischenberger JB, Bellanger RA, Hokanson JA, Snodgrass WR.

Ther Drug Monit. 1994 Dec;16(6):552-9.

PMID:
7878693
[PubMed - indexed for MEDLINE]
15.

Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy.

Maire P, Barbaut X, Vergnaud JM, el Brouzi M, Confesson MA, Pivot C, Chuzeville M, Ivanoff N, Brazier JL, Jelliffe RW.

Int J Biomed Comput. 1994 Jun;36(1-2):77-85.

PMID:
7927862
[PubMed - indexed for MEDLINE]
16.

Design of dosage regimens: a multiple model stochastic control approach.

Bayard DS, Milman MH, Schumitzky A.

Int J Biomed Comput. 1994 Jun;36(1-2):103-15.

PMID:
7927848
[PubMed - indexed for MEDLINE]
17.

Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples.

Jelliffe RW, Maire P, Sattler F, Gomis P, Tahani B.

Int J Biomed Comput. 1994 Jun;36(1-2):1-23. Review.

PMID:
7927847
[PubMed - indexed for MEDLINE]
18.

Prediction of future serum concentrations with Bayesian fitted pharmacokinetic models: results with data collected by nurses versus trained pharmacy residents.

Charpiat B, Breant V, Pivot-Dumarest C, Maire P, Jelliffe R.

Ther Drug Monit. 1994 Apr;16(2):166-73.

PMID:
8009565
[PubMed - indexed for MEDLINE]
19.

Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapy.

Jelliffe RW, Bayard D, Schumitzky A, Milman M, Van Guilder M.

Proc Annu Symp Comput Appl Med Care. 1994:972.

PMID:
7950076
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.

Jelliffe RW, Schumitzky A, Van Guilder M, Liu M, Hu L, Maire P, Gomis P, Barbaut X, Tahani B.

Ther Drug Monit. 1993 Oct;15(5):380-93. Review.

PMID:
8249044
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk